top of page

The Pennsylvania House of Representatives has given its final approval to a bill that would legalize marijuana through a system of state-owned dispensaries, sending it to the GOP-controlled Senate.

It has been a dizzying legislative process for the legislation, sponsored by Reps. Rick Krajewski (D) and Dan Frankel (D). The measure was introduced on Sunday, and it’s since moved through two committees, received initial approval from the full chamber on Tuesday and has now cleared the House on third reading in a 102-101 vote on Wednesday.

“After chairing six Health Committee hearings—meeting with stakeholders from industry, labor, social equity, criminal justice reform and more—I am proud and honored to be able to introduce legislation that I believe creates a balanced, responsible and robust framework,” Krajewski said on the floor.

“The reality is criminalization of cannabis does not work. It does not deter usage, it does not promote safety and it is not in the best interest of our commonwealth,” he said. “With legalization, we have the opportunity to rein in a market that is completely deregulated in terms of potency, content. labeling or advertising. We can promote public health, while also bringing in hundreds of millions of dollars that can be directed to communities hit the hardest by past criminalization.”

Frankel said “we set out to achieve something that no other state quite has: Put a permanent end to the criminalization of cannabis, protect the public health and make sure that Pennsylvanians and local businesses stand to benefit.”

“We followed the recommendations of the national experts. We created legislation that will legalize cannabis at the same time that it puts in place guardrails to protect children non-users and the health of our community,” he said.

The speedy process for the bill has given some lawmakers, particularly on the GOP side, heartburn. And on the floor on Wednesday, one member attempted to derail the bill by arguing it violates the state Constitution, in part because of provisions restricting court appeals of where cannabis shops could be located.

The motion to deem the bill unconstitutional failed in a 102-101 vote. A second motion challenging its legality on other grounds was ruled out of order and did not receive a vote.


Concerns about the legislation were also articulated during an earlier vote in the House Appropriations Committee on Wednesday before the legislation came back to the floor for a final vote.

The GOP minority chair of the panel, Rep. James Struzzi (R), said at the hearing that the proposal “creates significant concerns—both from a procedural standpoint and a physical standpoint on this Commonwealth.”

“This bill—170-plus pages, just introduced over the weekend essentially—we’ve had minimal time to process it,” Struzzi said. “We have a lot of questions. And this is a serious topic, as I think everyone will agree that will affect our Commonwealth for many, many years to come—good or bad, whether you stand for legalization or not.”

While there’s a competing bipartisan legalization measure that’s expected to be unveiled soon, this one already has 27 House Democrats signed on as cosponsors to the Krajewski-Frankel bill—more than one-fourth of the party’s caucus in the chamber.

“While our state is late to the game in terms of legalizing cannabis, this timing allows us to learn from the mistakes of other frameworks,” Krajewski said on the floor. To that end, he emphasized his sense that creating a “hybrid” model of public-private operations within the market represents a “bold new approach” that will boost the economy and avoid the “naked greed” of marijuana corporations that he argued has unfolded in other legal states.

“Massive multi-state cannabis companies have leveraged their existing medical and recreational footprints to control entire swaths of newly emerging recreational markets,” he said.

H.B. 1200 puts working Pennsylvanians first and prevents a corporate takeover of the cannabis market. It provides some of the boldest criminal record clearing processes to date. And it brings hundreds of millions to the neighborhoods most impacted by criminalization.

— Rep. Rick Krajewski (@RepKrajewski) May 7, 2025


“Where states have tried to level the playing field of social equity guidelines, those states have been terrorized with industry lawsuits,” Krajewski said. “This naked greed has led to near impossible conditions for small entrepreneurs to successfully compete in cannabis, enterprising business owners—many of whom are formerly incarcerated due to cannabis related offenses—were sold a fake gold rush dream by predatory investors when social equity businesses failed due to the volatility of a new market and aggressive multi-state operators, private equity was ready to swoop in and seize the remains.”

“A vote on HB 1200 is a vote to move us one step closer to modernization, and I ask for your support.”

On the House side, GOP members have raised various concerns about the policy change itself, such as potential impaired driving and workplace intoxication. The procedural and policy-specific concerns are expected to be amplified in the Republican-controlled Senate, where members will likely propose significant amendments to the proposed plan to have the state run marijuana shops.

Here’s what the bill, HB 1200, would accomplish: 

  • Under the bill, adults 21 and older would be able to legally possess and buy cannabis from stores licensed and operated by the Liquor Control Board (LCB), which currently controls alcohol sales in the state.

  • LCB would directly control the cannabis retail side of the industry, but it would also be responsible for licensing marijuana cultivation, processing, transportation and on-site consumption businesses that could be privately owned.

  • Cannabis shops could not sell more than 42.5 grams of marijuana, which would be the possession limit, to an adult within a 24-hour period.

  • Possession of up to three times the allowable amount would be decriminalized. Possessing up to double the amount (around three ounces) would be punishable by a maximum $250 fine, while possession of up to three times the legal amount would carry a maximum $500 fine.

  • Cannabis flower could not contain more than 25 percent THC, and edibles would be limited to five milligrams of THC per serving, with a maximum 25 milligrams total.

  • Adults who obtain a home cultivation permit from LCB at a cost of $100 annually would be able to grow up to two mature and two immature plants in a secure location at their residence for personal use.

  • Until marijuana sales begin, possession of small amounts of cannabis (defined as 30 grams or less) would be downgraded to a summary offense with a fine-only penalty of $250.

  • Marijuana products sold at licensed shops would be subject to a 12 percent excise tax.

  • Revenue from those taxes would be deposited in a Cannabis Revenue Fund, managed by the Department of Revenue (DOR). That fund would be used to cover administrative costs within the various departments that have a hand in regulating the cannabis program, including the facilitation of expungements for people with prior marijuana convictions for activity that would be made legal under the law. The remaining revenue would be distributed for a community reinvestment fund (50 percent), substance misuse treatment programs (10 percent), cannabis business development (5 percent), minority business development (2.5 percent) and grants to county courts that process expungements (2 percent).The rest would go into the state general fund.

  • Local municipalities could impose an additional 3 percent tax on on-site consumption lounges operating in their jurisdiction.

  • The Administrative Office of Pennsylvania Courts would be tasked with overseeing cannabis expungements, providing courts with a list of eligible cases that must be automatically sealed within two years.

  • A Social and Economic Equity Advisory Committee would be established under the bill to “promote inclusion and participation in the regulated cannabis industry, including through an indirect cannabis business, by persons that may qualify to be a social and economic equity applicant.” The committee would be responsible for a new Social and Economic Equity Loan and Grant Program that would “provide financial assistance to certified social and economic equity applicants, certified social and economic equity licensees and indirect cannabis businesses that meet the qualifications of a social and economic equity applicant.”

  • Eligible social and economic equity applicants are defined as those with a “household annual income below 200 percent of the Area Median Income in their county of residence,” and they’d also have to either have a minimum of 65 percent ownership by justice-impacted individuals or those who’ve spent five of the last 10 years in a designated historically impacted community.

  • The bill also contains rules around policies related to cannabis advertising, packaging and labeling—as well as requirements for businesses around ownership and a mandate to have a labor peace agreement in place for workers.

  • Public consumption would be prohibited, with offenders subject to a $100 fine for a first charge and up to $200 for subsequent offenses.

  • The legislation would also provide state-level protections, clarifying that residents who use cannabis in compliance with the law cannot be denied firearms rights, medical care, custody rights and professional licensing.

  • Workers who use cannabis off the job also could not be punished or fired based on the presence of THC metabolites in a drug tests—with key exceptions. Federally contracted workers could still face penalties, and employees would not be protected if the company has explicit prohibitions in its rules.

  • The legislation would not permit local municipalities to bar cannabis retailers from operating within their jurisdictions.

  • Possession of marijuana by an underage person would no longer carry the threat of jail time, replacing that penalty with escalating fines and a possible referral to a diversion program.

  • With respect to licensing, LCB would be required to issue licenses for 50 cultivators, 50 microcultivators, 50 processors, 50 microprocessors and up to 50 transporters. Those numbers could increase depending on the results of a market study.

  • If LCB determines that it’s in the state’s best interest to expand the market, it could issue licenses for existing medical cannabis cultivators and processors to service the adult-use market. Those prospective licensees would need to pay a non-refundable $15,000 application fee and $20 million for each license.

The largest challenge for the legislation going forward will likely come down to its proposal to have the state control cannabis sales—a regulatory model that exists in no other legal market in the U.S.

For what it’s worth, a recent poll found that Pennsylvania voters say they favor a model where cannabis is sold by licensed private businesses, rather than through a system of state-run stores.

Gov. Josh Shapiro (D) has repeatedly called for adult-use marijuana legalization, including the reform in his last three budget requests. However, he hasn’t endorsed the specific idea of having a state-controlled model.


Key Pennsylvania lawmakers have already made clear that they’re at odds on the path forward for legalization—while a top Republican senator recently dismissed the idea that the reform is achievable at all this session.

Frankel, for his part, said recently that “this will be the bill that we will see,” referring to his state-run legalization plan, adding that he’s worked “hand-in-hand” with Democratic leadership.

Rep. Abby Major (R)—who is sponsoring another forthcoming legalization bill that envisions a traditional private sales model alongside Rep. Emily Kinkead (D)—said on the floor on Wednesday that she stands opposed to the competing bill, emphasizing that she disagrees with the state-run stores proposal.

“Besides the fact that this would require state employees and the state itself to violate federal law—risking the freezing of employees, personal and state bank accounts and the state’s access to federal funding—this bill is a costly and inefficient approach for the commonwealth, posing significant risks to our economy, our medical program, social equity and public health and safety,” she said.

“House Bill 1200 is a deeply flawed proposal that drains our resources and weakens our financial footing long before we would ever see a return. It’s expensive, it’s inefficient, it delays revenue, it excludes those most impacted by prohibition, and it jeopardize the health and wellbeing of patients and consumers,” she said. “We must reject House Bill 1200 and instead look to a well-regulated private market—one that delivers immediate economic benefits supports entrepreneurs, protects patients, and ensures public safety.”

Today the #PAHouse passed the Cannabis Health & Safety Act!

This legislation would: ➕ Give adults 21+ the power of choice ➕ Bring home billions of dollars ➕ Create public retail with accountability ➕ Protect health & protect minors pic.twitter.com/LOT95wL3lr

— PA House Democrats (@PaHouseDems) May 7, 2025


While Democrats control the House and governor’s office, they will still need to reach a deal with the GOP-controlled Senate to effectuate change. And in addition to the conflicting perspectives among pro-legalization legislators, another potential barrier to reform is exactly that political dynamic.

Senate Majority Leader Joe Pittman (R) said that while he sees a “path forward” for enacting regulations for separate gaming-related reform, “I’m not seeing consensus between the four caucuses and the governor collectively that [marijuana legalization] should be a priority.”

Regardless of which direction Pennsylvania lawmakers do—or don’t—go on marijuana legalization session, a survey released last week shows a majority of adults in the state support the reform—and opposition to the policy change has fallen by nearly 50 percent over the last decade.

Kinkead has made the case in another recent interview that legalizing cannabis in Pennsylvania will help the state mitigate public health and safety concerns associated with the illicit market, including the fact that unregulated products can be laced with fentanyl.

The lawmaker previously introduced a separate bipartisan marijuana legalization bill, alongside 15 other cosponsors, last September. It did not advance, however.

Meanwhile, a Republican Pennsylvania senator recently called for the creation of a state “legacy” fund, using tax revenue from adult-use marijuana sales and gaming to make long-term investments in the Commonwealth’s economy.

The senator argued that, beyond using any resulting tax revenue to fund day-to-day projects and public services, the state should earmark a portion of those tax dollars for a fund to “provide a sustainable source of prosperity that lasts for generations.”

Pennsylvania House Speaker Joanna McClinton (D) recently said that Democrats are ready to pass a marijuana legalization bill this session, but that the party “will need Republican support” to get the job done—adding that it will be a “heavy lift.”

Another Democratic lawmaker said legislature is “substantially closer” to reaching a deal on marijuana legalization, and an initial vote on a bipartisan cannabis reform bill could come as early as this month.

Polls have shown bipartisan support for legalization among voters, but the reform has consistently stalled in the legislature, owing in large part to GOP opposition. But not all Republican members are against the policy change—and one recently said she felt her party should seize the “opportunity to snatch” the issue from Democrats.

Separately in March, the Pennsylvania House approved a bill sponsored by Frankel that’s meant to strengthen safety standards and oversight of the state’s medical marijuana program as lawmakers work to advance adult-use legalization.

While Pennsylvania’s medical cannabis program was enacted nearly a decade ago, lawmakers say the measure, which now heads to the Senate, is necessary to improve testing compliance, product audits and lab inspections, among other aspects of the industry.

Meanwhile, Pennsylvania Democratic lawmakers recently introduced a bill that would allow farmers and other small agriculture operators to sell marijuana they cultivate to existing growers and and processors if the state moves to legalize adult-use cannabis.

Separately, an independent Pennsylvania agency is projecting more tax dollars to be generated from adult-use marijuana sales compared to what the governor’s office has estimated, although it expects significantly less overall revenue from cannabis legalization due to differing views on licensing fees.

Pennsylvania officials have also launched a new survey that invites legal marijuana businesses across the country to provide information about their operations to help the state better understand the cannabis industry as lawmakers consider enacting adult-use legalization this session.

—Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

Also, in a video interview released in March, the governor emphasized that the state is “losing out” to others that have already enacted adult-use legalization, while maintaining a policy that’s enriched the illicit market.

“I think it’s an issue of freedom and liberty. I mean, if folks want to smoke, they should be able to do so in a safe and legal way,” he said. “We should shut down the black market—and, by the way, every state around us is doing it. Pennsylvanians are driving to those other states and paying taxes in those other states.”

Pennsylvania’s Republican attorney general recently said he wants to be a “voice for potential public safety risks” of enacting the governor’s proposal—though he said his office would be ready to enforce the new law if lawmakers did vote to pass it.

The state’s agriculture secretary separately told lawmakers that he’s fully confident that his department is in a “really good” position to oversee an adult-use marijuana program if lawmakers act.

Meanwhile, in February, top Pennsylvania police and health officials told lawmakers they are prepared to implement marijuana legalization if the legislature moves forward with the reform—and that they stand ready to work together as the details of legislation to achieve it are crafted.

Amid the growing calls for marijuana legalization in Pennsylvania, a GOP state senator said prohibition has been a “disaster,” and a regulated sales model for cannabis—similar to how alcohol and tobacco are handled—could serve as an effective alternative.

A Republican Pennsylvania senator also recently defended the push to legalize and regulate marijuana, calling it “the most conservative stance” on the issue.

DeSantis Says He’ll Sign Florida Bill To Criminalize Psychedelic Mushroom Spores

 
 
 

Pennsylvania lawmakers have advanced a pair of bills meant to prevent police from charging medical cannabis patients with impaired driving without proof of intoxication.

The Senate version of the legislation from Sen. Camera Bartolotta (R) cleared the Senate Transportation Committee, with amendments, in a unanimous vote last week.

Meanwhile, a House bill sponsored by Rep. Christopher Rabb (D), which is drafted differently but meant to achieve the same goal, passed that chamber’s Transportation Committee, 14-10.

Bartolotta said the measure—an earlier version of which also advanced last year—is designed to close a “loophole” in Pennsylvania’s medical cannabis law that currently permits law enforcement to arrest and prosecute patients for driving under the influence of marijuana without demonstrating that they are actively impaired.

“In 2016, we legalized the use of medicinal cannabis for a myriad of conditions. We were very careful with how the language was crafted in an attempt to avoid unintended consequences,” the senator said during the committee meeting. “Since that time, it has become very obvious that we overlooked one very important aspect.”

She pointed out that the majority of states, including some that have not legalized medical marijuana, require proof of impairment for DUI cases. But Pennsylvania’s law maintains that cannabis is considered a Schedule I drug for the purposes of impaired driving, regardless of a person’s status as a state-registered medical marijuana patient.

That’s led to situations where people have faced DUI charges after being stopped by police, identifying as a medical cannabis patient and then being required to submit to a drug test that showed the presence of inactive THC metabolites, which can stay in a person’s systems for days or weeks after using marijuana.

“No one should be put through this situation if they are legally and responsibly using medical cannabis in Pennsylvania,” Bartolotta said. “It is past time that we correct this egregious oversight.”

Her bill as amended in committee says that, for lawful medical cannabis patients, “proof of actual impairment shall be required if the individual is unable to safely drive, operate or be in actual physical control of a vehicle.” A medical marijuana certification “shall not, in and of itself, be sufficient evidence for a conviction.”

Also, having a medical cannabis card on its own could not be used as the basis to charge a person with a DUI, nor could it be used as grounds to require a drug test.

It further states that nothing about the bill would interfere in the enforcement of marijuana policies for federally regulated drivers operating commercial vehicles or school buses.

Under both the Senate and House bills, police would need to rely on standard field sobriety tests and drug recognition experts to make a determination that a medical marijuana patient was driving under the influence.

The House legislation that cleared committee was amended with language requested by the State Police and Pennsylvania Department of Transportation that, like the Senate version, clarifies that federally contracted or licensed commercial drivers are not covered under the protections.

“I take this very seriously as the father of a new driver,” Rabb, the sponsor, said during last week’s hearing. “I also take this seriously for those hundreds of thousands of Pennsylvanians who have drivers licenses and medical cannabis cards, who have no idea that they are imperiled just getting behind the wheel—not because they’re impaired, but because of how law enforcement may view them behind the wheel.”


The lawmaker said that, when he became a medical cannabis patient himself, he “didn’t think I would have any issues” because he doesn’t use intoxicating products, abides by the state’s law and doesn’t drive while impaired.

“I was wrong,” he said, noting that he’s received a “flurry” of messages from medical cannabis patients since first introducing his bill, detailing how their “lives have been turned upside down” because they were charged with DUIs without proof of impairment.

“All this bill seeks to do is to set the level playing field—same with any other medications,” he said. “Otherwise, medical cannabis shouldn’t be considered illegal, but it is. So, one standard. One standard.”

The text of his legislation would revise the state’s criminal code to specify that medical cannabis is not considered a Schedule I drug in suspected DUI cases, except for licensed commercial drivers.

My #cannabisDUI just passed in the #PAHouse Transportation Cmte meeting just now with bipartisan support!

This bill protects the 100s of thousands of law-abiding, UNIMPAIRED PA drivers who are responsible #medicalcannabis users from wrongful #DUI arrests.#cannabispic.twitter.com/Gavev4wUlZ

— Rep. Chris Rabb (@RepRabb) December 11, 2023


Rabb also secured the medical cannabis DUI protections reform as an amendment to a large-scale transportation bill that passed the full House in 2020. However, that bill was not ultimately enacted.

Both of the latest Senate and House proposals were approved in their respective committees during the final days of the 2023 session. Members are scheduled to come back into session in early February, after which point the bills could continue to advance, though at some point the chambers would need to reconcile the differing language.

Bartolotta said in a post on X (formerly Twitter) on Tuesday that she’s “very encouraged” that her bill “will be put up for a vote as soon as we get back.”

My bill passed out of committee and is now awaiting a floor vote in the Senate. We will be back to session in February and I am very encouraged that it will be put up for a vote as soon as we get back.

— Camera Bartolotta 🇺🇸 (@CameraForSenate) December 19, 2023


While the reform appears positioned to advance further, advocates remain frustrated that lawmakers in the divided legislature have so far failed to enact broader marijuana legalization, especially as neighboring states implement their own adult-use markets.

However, as momentum has built, a Pennsylvania House committee held a second informational hearing on marijuana legalization last week. After Ohio voters’ decision last month to legalize recreational cannabis, both Pennsylvania’s governor and U.S. Sen. John Fetterman (D-PA) have said it’s time for Pennsylvania to make the change, too.

Fetterman said recently that the state is being “lapped” on marijuana policy as neighboring states enact legalization.

Bartolotta as well as pro-legalization Sen. Sharif Street are separately seeking co-sponsors for a more modest change, circulating a legislative proposal that would decriminalize marijuana by downgrading simple possession from a misdemeanor crime to a civil offense.

Meanwhile, Gov. Josh Shapiro (D) signed a bill last week to allow all licensed medical marijuana grower-processors in the state to serve as retailers and sell their cannabis products directly to patients. Independent dispensaries could also start cultivating their own marijuana.

Colorado Panel Hears Ballot Proposal To Let Marijuana Users Obtain Concealed Carry Permits

 
 
 

An attempt to provide protections for Pennsylvania medical marijuana patients from being charged with driving under the influence was derailed in the legislature this week, apparently due to pushback by the state police association.

Lawmakers have been working to pass standalone legislation on the issue, ensuring that registered patients aren’t penalized for having cannabis metabolites in their system, which can be detected for weeks after a person consumers cannabis. During a floor session in the House on Monday, Rep. Chris Rabb (D) sought to attach the language of the legislation to a broader vehicle-related bill as an amendment.

But the amendment was later withdrawn from consideration after the Republican co-prime sponsor, Rep. Todd Polinchock (R), pulled his name from the standalone bill, which Rabb said was “due to concerns expressed to him” by the Pennsylvania State Troopers Association.

Dem Chair of the #PAHouse Transportation Cmte, Rep. Mike Carroll, just spoke on my amendment based on bipartisan legislation, HB900. But as of earlier today, my R co-prime sponsor has removed his name from the bill due to concerns expressed to him — not me — from @PAStatePolice. https://t.co/rnsQ2wQyg8

— Rep. Chris Rabb (@RepRabb) November 15, 2021


The association recently circulated a position statement expressing opposition to the proposal, according to the lawmaker. Rabb told Marijuana Moment that he did not see the statement until after he learned that Polinchock removed his name from the legislation.

Rabb met with a liaison for the police association on Thursday—days after the House floor action—and said the group expressed concern about “the potential muddling of what law enforcement could do in terms of proving impairment.”

“There’s a perception—generally speaking, not just with state troopers or law enforcement, but generally—that somehow this amendment to this bill, which is identical to the standalone legislation I introduced, would somehow give impaired drivers who were impaired by cannabis a free pass, which it wouldn’t,” Rabb said. “It merely seeks to have parity for drivers, irrespective of the prescribed medication.”

You’ll have to ask the state police who have chosen not share their concerns with me — & perhaps not even the PA District Attorneys Ass’n which supports HB900 because having traces of #cannabis in one’s system — even weeks after it has been ingested — does NOT prove impairment.

— Rep. Chris Rabb (@RepRabb) November 15, 2021


Meanwhile, bipartisan Pennsylvania senators on Wednesday said they are introducing a bill that would also impact medical cannabis patients, allowing them to cultivate their own plants for personal use.

Rep. Mike Carroll (D), co-chair of the House Transportation Committee, spoke about the DUI protections issue on the floor on Monday before withdrawing the amendment. He said “we simply cannot have people using medical marijuana charged and convicted of a DUI when they’re not impaired.”


“It’s patently unfair and currently happening,” Carroll said. “District attorneys across the state have reached out to me and asked that something be done. House Bill 900 is the remedy. And in the absence of House Bill 900, this amendment is the remedy.”

After another lawmaker moved to table the amendment, Carroll, who did not mention the police concerns on the floor, said that other members of the legislature had asked him to withdraw the measure, which he then did.

Marijuana Moment is already tracking more than 1,200 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

Rabb, who is himself a medical cannabis patient and a founding member of the bicameral Pennsylvania Cannabis Caucus, said next steps for advancing the reform would involve “getting more stakeholders in law enforcement” to offer their support and promoting “public literacy around this issue—not just cannabis, but how it intersects with law enforcement.”

The broad driving legislation the Rabb wanted his amendment attached to has now passed the House and is on its way to the Senate.

In that chamber, the Transportation Committee held a hearing in September on a nearly identical standalone bill that’s being sponsored by Sen. Camera Bartolotta (R).

Health professionals, lawyers and law enforcement officials highlighted the unique complications that cannabis patients and police face under the current statute and the constitutionality of the proposed reform.

The legislation would specifically amend state law to require proof of active impairment before a registered patient could be prosecuted for driving under the influence. The current lack of specific protections for the state’s roughly 368,000 patients puts them in legal jeopardy when on the road, supporters say.

The measure would essentially make it so medical cannabis would be treated the same by law enforcement as Schedule II and III drugs such as prescription opioids and anti-anxiety medication.

Bartolotta first introduced an earlier version of her bill in June 2020. She said at the time that the state needs to “ensure that the legal use of this medicine does not give rise to a criminal conviction.”

Months after the standalone reform legislation was introduced, the Pennsylvania House did approve a separate amendment that would enact the policy change.

Pennsylvania legalized medical marijuana in 2016, with the first dispensaries in the state opening in 2018. But the state’s zero-tolerance DUI law still doesn’t reflect those changes.

Experts and advocates have emphasized that evidence isn’t clear on the relationship between THC concentrations in blood and impairment.

A study published in 2019, for example, concluded that those who drive at the legal THC limit—which is typically between two to five nanograms of THC per milliliter of blood—were not statistically more likely to be involved in an accident compared to people who haven’t used marijuana.

Separately, the Congressional Research Service in 2019 determined that while “marijuana consumption can affect a person’s response times and motor performance… studies of the impact of marijuana consumption on a driver’s risk of being involved in a crash have produced conflicting results, with some studies finding little or no increased risk of a crash from marijuana usage.”

Outside of the driving issue, Pennsylvania lawmakers are also pursuing separate marijuana reforms in the state.

For example, a lawmaker introduced a bill last month to expand the number of medical marijuana cultivators in the state, prioritizing small farms to break up what she characterized as a monopoly or large corporations that’s created supply problems.

The legislation would still not allow medical cannabis patients to grow their own medicine, however. Efforts to add that right have been defeated in the legislature.

A much-anticipated bipartisan Senate bill to legalize marijuana in Pennsylvania that has been months in the making was formally introduced earlier last month.

Sens. Dan Laughlin (R) and Sharif Street (D) unveiled the nearly 240-page legislation months after first outlining some key details back in February. It would allow adults 21 and older to purchase and possess up to 30 grams of cannabis, five grams of marijuana concentrate products and 500 milligrams of THC contained in cannabis-infused products.

Meanwhile, Rep. Amen Brown (D) recently announced his intent to file a reform bill that he’ll be working on with Sen. Mike Regan (R), who expressed his support for the policy change a day earlier.

Additionally, a separate pair of state lawmakers—Reps. Jake Wheatley (D) and Dan Frankel (D)—formally unveiled a legalization bill they’re proposing.

While each measure generally seeks and end to marijuana criminalization by creating a regulated, commercial model for cannabis, there are some provisions that make each piece of legislation unique. For example, the proposals vary in how they would approach taxes, revenue and social equity.

While these recent moves to enact reform in the GOP-controlled legislature are encouraging to advocates, a spokesperson for House Majority Leader Kerry Benninghoff (R) recently tempered expectations, saying that there’s “no significant support for the legalization of recreational marijuana in the House Republican caucus.”

Lt. Gov. John Fetterman (D), who is running for U.S. Senate, told Marijuana Moment in a recent phone interview that he’s optimistic about the prospects of reform with these latest proposals, though he acknowledged that there may be disputes between legislators over how tax revenue should be distributed.

Gov. Tom Wolf (D), for his part, has said that a bipartisan approach to legalization “would be a great thing. I think the time is right.”

Philadelphia voters also approved a referendum on marijuana legalization this month that adds a section to the city charter saying that “the citizens of Philadelphia call upon the Pennsylvania General Assembly and the Governor to pass legislation that will decriminalize, regulate, and tax the use, and sale to adults aged 21 years or older, of cannabis for non-medical purposes.”

Wolf said earlier this year that marijuana legalization was a priority as he negotiated the annual budget with lawmakers. However, his formal spending request didn’t contain legislative language to actually accomplish the cannabis policy change.

The governor, who signed a medical cannabis expansion bill in June, has repeatedly called for legalization and pressured the Republican-controlled legislature to pursue the reform since coming out in favor of the policy in 2019. Shortly after he did that, a lawmaker filed a separate bill to legalize marijuana through a state-run model.

In May, Wolf pardoned a doctor who was arrested, prosecuted and jailed for growing marijuana that he used to provide relief for his dying wife. That marked his 96th pardon for people with cannabis convictions through the Expedited Review Program for Non-Violent Marijuana-Related Offenses that’s being run by the Board of Pardons.

A survey from Franklin & Marshall College released this week found that 60 percent of Pennsylvania voters back adult-use legalization. That’s the highest level of support for the issue since the firm started polling people about it in 2006.

Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill

 
 
 

Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page